scholarly journals Health-Related Quality of Life in KEYNOTE-010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed Death Ligand 1–Expressing NSCLC

2019 ◽  
Vol 14 (5) ◽  
pp. 793-801 ◽  
Author(s):  
Fabrice Barlesi ◽  
Edward B. Garon ◽  
Dong-Wan Kim ◽  
Enriqueta Felip ◽  
Ji-Youn Han ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document